Peel Therapeutics: Closes $9M Financing Round

Peel Therapeutics Closes $9M Financing Round

  • Peel Therapeutics, a Salt Lake City, UT-based clinical-stage biotech company, secured $9M in funding, bringing its total seed financing to $36M
  • The company intends to use the funds to advance clinical and pre-clinical programs
  • PeelTherapeutics is a clinical-stage biotech company that is advancing a therapeutic pipeline to treat a spectrum of devastating conditions, with a near-term focus on cancer and inflammation
  • The company has raised a total of $36M in seed financing, plus over $3M in non-dilutive capital
  • Peel also expanded its Board of Directors to support and guide the company through this rapid growth stage
  • The new additions include Ryan Watts, CEO, Denali Therapeutics and Carin Canale-Theakston, CEO, Evoke Canale
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

LSEG Launches Blockchain-Based Digital Settlement Network

This new platform aims to enhance financial settlement processes.Highlights: LSEG has launched a blockchain-enabled digital settlement network.The platform...

SWIFT to Build Shared Ledger for Tokenised Asset Transactions

New initiative aims to streamline digital asset transactions globally.Highlights: SWIFT is launching a shared ledger for tokenised assets.The...

Keye Launches AI Co-Pilot for Private Equity Due Diligence

Innovative tool aims to streamline investment analysis and decision-making.Highlights: Keye introduces an AI co-pilot for private equity due...

Cosegic Strengthens Financial Crime Expertise with Fintrail Acquisition

The acquisition enhances Cosegic's capabilities in combating financial crime.Highlights: Cosegic acquires Fintrail to enhance financial crime capabilities.The acquisition...